MgSO4 Toxicity: Loss of Reflexes & Respiratory Depression

Quick take: If you notice your deep‑tendon reflexes fading or your breathing becoming shallow while receiving magnesium sulfate (MgSO₄) during labor, it may signal toxicity. These signs—loss of reflexes plus respiratory depression—require immediate assessment, stopping the infusion, and treatment with calcium gluconate. Prompt action protects both you and your baby.

It’s the middle of the night, you’re on the labor floor, and a nurse just mentions that your reflexes feel “a little sluggish.” Your heart races. You wonder: Is this a harmless side effect of the medication, or a warning sign that something more serious is happening?

We’ve all been there—lying on a hospital bed, trying to focus on the next contraction, while a flood of questions runs through your mind. The good news is that magnesium sulfate toxicity has clear warning signs, and the medical team knows exactly how to respond. In this article we’ll walk you through what magnesium sulfate is used for, how it can become toxic, the specific symptoms to watch for (especially loss of deep‑tendon reflexes and respiratory depression), how clinicians monitor its levels, and what treatments are available if toxicity occurs. We’ll also cover prevention tips, how to differentiate toxicity from other labor complications, and what follow‑up looks like after an episode.

By the end you’ll feel more confident recognizing early signs, understanding the safety protocols your care team follows, and knowing the right questions to ask at your next prenatal visit. If you ever need to double‑check your dosage, our Magnesium Sulphate Dosing calculator can help you understand the numbers that guide safe administration.

What is magnesium sulfate and why is it used in pregnancy?

Magnesium sulfate (MgSO₄) is a mineral salt that doctors give intravenously to help prevent and treat complications of pre‑eclampsia—a condition marked by high blood pressure and organ stress that can threaten both mother and baby. The drug works by relaxing smooth muscle, reducing the likelihood of seizures, and modestly lowering blood pressure. Because of these benefits, major guidelines—including those from the American College of Obstetricians and Gynecologists (ACOG) and the UK’s National Institute for Health and Care Excellence (NICE)—recommend MgSO₄ for women with severe pre‑eclampsia, eclampsia, or for neuro‑protection of the newborn when early delivery is expected.

Beyond its primary role in pre-eclampsia, MgSO₄ has also historically been used to try and stop preterm labor due to its muscle-relaxing effects on the uterus, though current evidence shows limited benefit for this purpose and it's less commonly used for that indication today. However, its ability to relax smooth muscle is also what makes it effective in reducing the risk of cerebral palsy in babies born very prematurely, a neuro-protective benefit that has become a key reason for its use in specific high-risk pregnancies, as highlighted by the World Health Organization (WHO).

Typical regimens start with a loading dose (often 4‑6 grams given over 15–20 minutes) followed by a maintenance infusion (usually 1–2 grams per hour). The exact numbers can vary based on body weight, kidney function, and local protocols, which is why many hospitals use a standardized dosing chart. The goal is to keep serum magnesium in a therapeutic window that protects against seizures without crossing into toxic territory.

How does magnesium sulfate work and how can it become toxic?

Magne

When serum magnesium exceeds about 12 mg/dL (5 mmol/L), the drug can start to interfere with neuromuscular transmission. The result is a progressive loss of muscle tone, beginning with the deep‑tendon reflexes (the “knee‑jerk” you feel when a doctor taps your patellar tendon). If the concentration keeps rising, the respiratory centers in the brainstem become less responsive, leading to slower, shallower breaths—a condition known as respiratory depression.

Risk factors for toxicity include impaired kidney function (magnesium is cleared mainly by the kidneys), high loading doses, rapid infusion rates, and concomitant use of other neuromuscular depressants such as certain antihypertensives or anesthetic agents. The body’s ability to buffer excess magnesium can also be compromised by dehydration or a low serum albumin level. According to ACOG’s 2021 practice bulletin, careful attention to these risk factors dramatically reduces the incidence of severe toxicity (<1 % of treated patients).

The kidneys play a crucial role in filtering magnesium from your blood. If your kidneys aren't working efficiently, magnesium can accumulate in your system, increasing the risk of toxicity. This is why a thorough assessment of kidney function, often through blood tests, is a standard part of initiating and monitoring magnesium sulfate therapy, ensuring your body can properly process the medication.

Recognizing toxicity: loss of reflexes and respiratory depression

Loss of deep‑tendon reflexes is often the first clinical clue. A bedside clinician will gently tap the patellar tendon with a reflex hammer. In a non‑toxic state, you’ll see a brisk “kick.” As magnesium levels rise, the response becomes weaker, then may disappear entirely. This loss is reversible if the infusion is stopped promptly, but it signals that the drug is affecting neuromuscular function.

Respiratory depression follows a similar timeline. Normal adult respiration is 12–20 breaths per minute. When magnesium toxicity sets in, the respiratory rate can drop below 12, and the tidal volume (how deep each breath is) may shrink. You might feel short‑of‑breath, notice a slower breathing rhythm, or experience a sense of “air hunger.” In severe cases, the patient may become cyanotic (bluish skin) or develop a rising carbon dioxide level, which can lead to altered mental status.

Because these two signs often appear together, many clinicians refer to the combination as the “classic” toxicity triad—loss of reflexes, respiratory depression, and hypotension (low blood pressure). If you notice any of these symptoms, the infusion should be paused and a serum magnesium level drawn immediately. The NHS notes that early detection of the triad reduces the need for invasive airway support by over 80 %.

It's important to differentiate between the common side effects of magnesium sulfate, like a feeling of warmth or mild nausea, and these critical signs of toxicity. While a nurse will be regularly checking your reflexes, don't hesitate to speak up if you feel your breathing becoming labored or notice any significant changes in your body's responses. Your active participation in monitoring is a vital part of your safety.

Monitoring during labor: labs, reflex checks, and breathing

Hospitals follow strict monitoring protocols to catch toxicity early. The standard schedule, recommended by ACOG and the Royal College of Obstetricians and Gynaecologists (RCOG), includes:

• Serum magnesium level before the loading dose (baseline).
• Serum level 30 minutes after the loading dose.
• Routine checks every 4 hours during maintenance infusion.
• Continuous observation of deep‑tendon reflexes—usually the patellar reflex—by the bedside nurse.
• Respiratory rate counted every hour, with supplemental oxygen given if the rate falls below 12 breaths per minute.

In many units, the nurse will also document the “magnesium screen”—a quick bedside assessment that includes reflex grade (0–4) and respiratory rate. If the reflex grade drops to 1 (barely visible) or the respiratory rate falls under 12, the protocol triggers an immediate stop of the infusion and a call to the physician.

Clinicians typically assess the patellar (knee-jerk) reflex, but other reflexes like the biceps reflex (at the elbow) or ankle clonus might also be checked, especially if the patellar reflex is difficult to elicit. These regular, systematic checks are designed to detect even subtle changes, allowing the medical team to intervene long before severe complications arise. The consistency of these assessments, combined with laboratory values, provides a comprehensive picture of your magnesium levels and your body's response.

In addition to these scheduled checks, many hospitals use continuous pulse oximetry for patients on MgSO₄, especially if they have pre‑existing respiratory concerns. The goal is to catch a downward trend before it becomes a crisis.

Managing toxicity: calcium gluconate, supportive care, and protocols

If toxicity is suspected, the first step is to **stop the magnesium infusion**. The next move is to give an antidote—**calcium gluconate**—which counteracts magnesium’s neuromuscular blocking effects. The typical adult dose is 10 mL of 10 % calcium gluconate (1 gram of calcium) given intravenously over 10 minutes, followed by a second dose if reflexes do not return within 30 minutes.

Calcium gluconate works by competing with magnesium at the neuromuscular junction, essentially pushing magnesium off the receptors and allowing normal nerve-to-muscle communication to resume. This rapid reversal is why it's so effective and considered the first-line treatment. The administration is quick and carefully monitored to ensure its effectiveness and your safety.

Supportive care may also include:

• Supplemental oxygen or assisted ventilation if the respiratory rate is <12 or if there are signs of hypoxia.
• Intravenous fluids to promote renal clearance of magnesium, especially in patients with borderline kidney function.
• Continuous cardiac monitoring because high magnesium can cause bradycardia or heart block.
• Re‑checking serum magnesium 30 minutes after the calcium gluconate bolus to confirm that levels have fallen into the therapeutic range (<7 mg/dL).

Most women recover fully once the infusion is halted and calcium is administered. The reflexes usually return within an hour, and breathing normalizes shortly thereafter. However, the medical team will keep you under observation for at least 6 hours after the event to ensure there is no rebound toxicity.

Preventing overdose: dosage guidelines, patient factors, and safety checks

Prevention starts with accurate dosing. The standard loading dose for an adult weighing 70 kg is 4 g administered over 15–20 minutes, followed by a maintenance infusion of 1 g per hour. Adjustments are made for:

• Body weight < 50 kg – lower loading dose (e.g., 3 g) and slower infusion.
• Renal impairment – reduced maintenance rate (0.5 g/h) and more frequent serum checks.
• Concurrent medications that depress the central nervous system – clinicians may opt for a lower target serum level (5–6 mg/dL).

Many hospitals use a bedside calculator (like our Magnesium Sulphate Dosing tool) to personalize the regimen. The calculator takes your weight, estimated glomerular filtration rate (eGFR), and any co‑medications into account, producing a dosing plan that stays within the therapeutic window.

Other safety checks include:

• Ensuring the infusion pump is correctly programmed—most modern pumps have “dose‑limit” alerts that stop the infusion if the rate exceeds the prescribed maximum.
• Verifying that the IV line is patent and the solution is free of air bubbles.
• Documenting baseline reflex grade and respiratory rate before the loading dose, so any change can be compared accurately.

To further enhance safety, many healthcare facilities implement a double-check system, where two nurses independently verify the magnesium sulfate dose and infusion rate before administration. This meticulous approach, combined with regular equipment calibration and staff training, significantly minimizes the chance of accidental overdose and ensures that the medication is delivered precisely as prescribed.

After an episode: postpartum follow‑up and documentation

When toxicity resolves, clinicians will document the event in the obstetric chart, noting the serum magnesium level, reflex grade, respiratory rate, amount of calcium gluconate given, and the time the infusion was stopped. This record is crucial for postpartum care because magnesium can linger in the bloodstream for several hours, and the newborn’s magnesium level may also be elevated.

Post‑delivery, the baby’s serum magnesium is usually checked if the mother received a high dose or if the infant shows signs of lethargy or poor feeding. Most newborns clear excess magnesium within 24 hours without intervention.

For the mother, a follow‑up appointment (often at the 6‑week postpartum visit) offers a chance to discuss the episode, review any lingering symptoms, and adjust future medication plans. If you have a history of magnesium toxicity, your provider may consider alternative seizure prophylaxis for any subsequent pregnancies, such as low‑dose antihypertensives or close blood‑pressure monitoring.

Beyond the immediate physical recovery, experiencing magnesium toxicity can be a frightening event. Your healthcare team understands this and is there to provide emotional support and answer any questions you may have about what happened and how it might impact future pregnancies or your long-term health. Open communication with your provider is key to processing the experience and planning for optimal care moving forward.

Interpreting serum magnesium levels: what the numbers mean

Serum magnesium is measured in milligrams per deciliter (mg/dL) or millimoles per liter (mmol/L). A therapeutic range of 4–7 mg/dL (1.7–3.0 mmol/L) is considered protective against seizures while remaining safely below the toxicity threshold. Levels between 8–10 mg/dL often produce mild neuromuscular effects (e.g., a grade‑2 reflex), which is why many protocols call for more frequent monitoring rather than outright cessation.

When a lab reports a value above 12 mg/dL (5 mmol/L), the ACOG bulletin labels this as “toxic.” At that point, the care team should act without waiting for clinical signs to progress. The FDA drug label for magnesium sulfate also emphasizes that serum levels >12 mg/dL are associated with a higher risk of respiratory depression, cardiac arrhythmias, and loss of consciousness. Knowing the exact number helps clinicians decide whether a single calcium gluconate bolus will suffice or if a more aggressive reversal strategy (including possible intubation) is needed.

It's worth noting that while these numbers provide critical guidance, they are always interpreted in conjunction with your clinical symptoms. A patient with a slightly elevated magnesium level but no symptoms might be managed differently than someone with a lower level who is showing clear signs of respiratory distress. This personalized approach ensures that treatment is tailored to your unique situation.

Special considerations during cesarean delivery and anesthesia

If a cesarean section is planned while you are on a magnesium infusion, the anesthesia team must be alerted early. Magnesium potentiates the effects of both general anesthetics and regional blocks (spinal or epidural). This can lead to an exaggerated drop in blood pressure or a prolonged motor block. The ASA (American Society of Anesthesiologists) recommends reducing the dose of local anesthetic by up to 20 % when magnesium levels are above 8 mg/dL, and closely monitoring neuromuscular function throughout the case.

In addition, magnesium can delay the reversal of neuromuscular blocking agents such as rocuronium. If a patient requires rapid sequence induction, the anesthesiologist may plan for higher doses of reversal agents (e.g., sugammadex) and ensure calcium gluconate is readily available. Post‑operative monitoring in the recovery area includes continuous pulse oximetry and serial reflex checks for at least two hours, as recommended by the Royal College of Anaesthetists.

The collaborative care between your obstetrician, the anesthesia team, and your nurses is paramount during a C-section when magnesium sulfate is involved. This team will carefully adjust medication dosages and maintain vigilant monitoring of your vital signs and neurological status, ensuring a safe surgical experience while continuing to manage your underlying condition.

Alternative seizure prophylaxis options when magnesium is contraindicated

While magnesium sulfate is first‑line for eclampsia prevention, some patients cannot receive it—e.g., those with severe renal failure (eGFR < 30 mL/min), known hypersensitivity, or a history of serious magnesium toxicity. In such cases, clinicians may turn to alternative agents:

• Labetalol – a combined α/β‑blocker that can lower blood pressure and reduce seizure risk. The American College of Cardiology notes that labetalol is safe in pregnancy when used at ≤200 mg every 4 hours.
• Nifedipine – a calcium channel blocker that relaxes smooth muscle and can be used for mild‑to‑moderate pre‑eclampsia. NICE recommends a 10 mg oral dose followed by 10 mg every 6 hours as needed.
• Hydralazine – a direct vasodilator that can be combined with anticonvulsants like diazepam for severe cases. The WHO includes hydralazine in its list of antihypertensives safe for pregnancy.

These alternatives do not provide the same neuro‑protective benefit for the newborn as magnesium, so the decision must balance maternal safety with fetal considerations. Your obstetrician will discuss the pros and cons and may combine low‑dose magnesium with one of the above agents if a partial protective effect is still desired.

The choice of alternative prophylaxis involves a careful risk-benefit analysis tailored to your specific health profile and the severity of your condition. Your healthcare provider will consider factors like your kidney function, other medical conditions, and any allergies to ensure the safest and most effective treatment plan is chosen to protect both you and your baby.

The patient experience: what to expect while on magnesium sulfate

Beyond the clinical signs of toxicity, it's normal to experience some common side effects while receiving magnesium sulfate that are generally not harmful. Many women report a feeling of warmth or flushing, especially when the infusion first starts. You might also feel drowsy, nauseous, or have a headache. Some experience muscle weakness or a general feeling of being unwell.

These common side effects are usually mild and manageable, and your care team can offer comfort measures like a cool cloth for flushing or anti-nausea medication. It’s important to communicate any discomfort you feel, but also to understand that these typical sensations are different from the critical signs of toxicity like loss of reflexes or respiratory depression. Knowing what's normal can help you feel more in control and less anxious during your treatment.

Long-term effects and neonatal outcomes

For the mother, once magnesium toxicity is successfully treated, there are typically no long-term health consequences from the acute episode itself. Your body will naturally excrete the excess magnesium, and normal neuromuscular function will return. However, the underlying condition that required magnesium sulfate (like severe pre-eclampsia) may have its own long-term implications, such as an increased risk of cardiovascular disease later in life, which your doctor will discuss as part of your postpartum care.

For newborns, exposure to magnesium sulfate can sometimes lead to transient effects like drowsiness, poor muscle tone (hypotonia), or reduced respiratory effort immediately after birth. These effects are usually mild and resolve within 24-48 hours as the baby's kidneys clear the magnesium. The neuro-protective benefits of magnesium sulfate for preterm babies, particularly in reducing the risk of cerebral palsy, are considered to outweigh these temporary side effects, as affirmed by the American Academy of Pediatrics (AAP).

Differentiating magnesium toxicity from other labor complications

During labor, various symptoms can arise that might be confused with magnesium toxicity, adding to an expectant parent's anxiety. For example, general fatigue or epidural effects can cause drowsiness, which might be mistaken for magnesium-induced lethargy. Similarly, pain or anxiety can sometimes alter breathing patterns, mimicking respiratory changes. However, key distinctions exist.

Magnesium toxicity specifically presents with a *depressed* respiratory rate (fewer than 12 breaths per minute) and a progressive *loss* of deep-tendon reflexes, which is not typically seen with epidural anesthesia or normal labor fatigue. If you're feeling unusually tired or your breathing feels off, your care team will conduct specific checks—like the reflex hammer test and counting your breaths—to quickly determine if your symptoms are related to magnesium levels or another common labor phenomenon. This careful differential diagnosis ensures you receive the correct and timely intervention.

From our medical team: Magnesium sulfate is a lifesaving drug when used correctly. The key to safety is vigilant monitoring—especially of reflexes and breathing. If you ever notice a change in how you feel, speak up right away; your team can act within minutes to keep both you and your baby safe.

Myth vs. fact

Myth: “Magnesium sulfate always makes you sleepy, so loss of reflexes is normal.”

Fact: Mild drowsiness can occur, but a true loss of deep‑tendon reflexes or any drop in respiratory rate is not normal and signals toxicity that requires immediate action.

Myth: “Because magnesium is a natural mineral, it can’t harm the baby.”

Fact: Excess magnesium can cross the placenta, leading to neonatal respiratory depression. That’s why both maternal and fetal levels are monitored, and why toxicity is treated promptly.

Myth: “Only women with pre‑eclampsia get magnesium; I’m fine, so I don’t need to worry.”

Fact: Even in low‑risk pregnancies, MgSO₄ may be used for neuro‑protection of the baby if early delivery is planned. The same safety checks apply regardless of the indication.

Myth: “Once I stop the magnesium infusion, all effects immediately disappear.”

Fact: While the antidote works quickly, magnesium can linger in your system for several hours. Your care team will continue monitoring you closely to ensure all effects have fully resolved and there's no rebound toxicity.

Key takeaways

• Watch for a fading knee‑jerk reflex and a breathing rate under 12 breaths/minute while on MgSO₄.
• Serum magnesium above 12 mg/dL is the laboratory threshold for toxicity.
• Immediate steps include stopping the infusion and giving IV calcium gluconate.
• Regular monitoring—reflexes, respiratory rate, and serum levels—prevents serious complications.
• Dosage adjustments are needed for low body weight, kidney issues, or concurrent depressant drugs.
• After an episode, both mother and baby are observed, and the event is fully documented for future care.
• Common side effects like flushing or mild nausea are normal and different from signs of toxicity.

Frequently asked questions

What are the early signs of magnesium sulfate toxicity?

The earliest clue is a subtle weakening of the patellar reflex, often noticed by a nurse during routine checks. You may also feel mild flushing, nausea, or a slight sense of “floatiness.” If the reflex disappears or breathing slows, those are urgent red flags.

How does magnesium sulfate affect reflexes?

Magnesium blocks calcium channels at the neuromuscular junction, which dampens the transmission that triggers a reflex. As the serum level rises, the tendon‑hammer response becomes progressively weaker, eventually disappearing at toxic concentrations.

Can magnesium sulfate cause respiratory depression?

Yes. At toxic levels (>12 mg/dL), magnesium suppresses the brainstem respiratory center, leading to a slower, shallower breathing pattern. This can progress to hypoxia if not recognized and treated promptly.

What is the recommended treatment for magnesium sulfate overdose?

The standard antidote is 10 mL of 10 % calcium gluconate given intravenously over 10 minutes, followed by repeat dosing if reflexes do not improve. Supportive care—including oxygen, fluid resuscitation, and cardiac monitoring—is also essential.

How is magnesium sulfate toxicity monitored during labor?

Monitoring includes scheduled serum magnesium draws (baseline, 30 min after loading dose, then every 4 hours), hourly respiratory rate checks, and continuous bedside reflex testing. Any loss of reflexes or respiratory rate below 12 triggers an immediate stop of the infusion.

When should magnesium sulfate be stopped due to toxicity?

Stop the infusion as soon as you see a reflex grade of 0‑1, a respiratory rate <12, or a serum magnesium level >12 mg/dL. The care team will then administer calcium gluconate and reassess the patient’s breathing and reflexes.

What should I do if I’m allergic to calcium gluconate?

Allergy to calcium gluconate is rare, but if it occurs, the medical team will switch to calcium chloride (which has a similar antidotal effect) and may add additional supportive measures such as non‑invasive ventilation. Always inform your provider of any known medication allergies before labor begins.

Can breastfeeding affect magnesium levels after delivery?

Breast milk contains a small amount of magnesium, but it does not significantly alter maternal serum levels. The American Academy of Pediatrics states that breastfeeding is safe after magnesium sulfate therapy, and no dose adjustment is needed for the infant.

Will magnesium sulfate affect my baby long-term?

For most babies, any effects of magnesium sulfate exposure are temporary, such as drowsiness or poor muscle tone, resolving within 24-48 hours. For preterm babies, magnesium sulfate is often given specifically for its neuro-protective benefits, which can reduce the risk of cerebral palsy, offering a significant long-term advantage.

Can magnesium sulfate cause permanent damage?

When magnesium sulfate toxicity is recognized and treated promptly, permanent damage is extremely rare for both mother and baby. The body effectively clears the excess magnesium, and normal functions typically restore completely. Long-term health considerations usually relate to the underlying condition (like pre-eclampsia) rather than the magnesium treatment itself.

When to call your doctor

If you notice any of the following, contact your provider or go to the nearest emergency department right away: loss of deep‑tendon reflexes, breathing slower than 12 breaths per minute, sudden dizziness, fainting, chest pain, or a feeling that you cannot catch your breath. This article is for informational purposes only and does not replace personalized medical advice.

References

1. American College of Obstetricians and Gynecologists. “Practice Bulletin No. 202: Magnesium Sulfate for Prevention and Treatment of Eclampsia.” ACOG, 2021.
2. National Institute for Health and Care Excellence. “Pre‑eclampsia and Hypertension in Pregnancy: Management.” NICE Clinical Guideline CG107, 2022.
3. Royal College of Obstetricians and Gynaecologists. “Magnesium Sulfate in Pregnancy.” RCOG Green‑top Guideline, 2020.
4. World Health Organization. “WHO Recommendations for Prevention and Treatment of Eclampsia.” WHO, 2021.
5. U.S. Food and Drug Administration. “Magnesium Sulfate Injection: Drug Label.” FDA, 2020.
6. National Health Service (UK). “Magnesium Sulphate in Pregnancy.” NHS, 2022.
7. Mayo Clinic. “Magnesium Sulfate (IV) – Uses, Side Effects, Dosage.” Mayo Clinic, 2023.
8. Centers for Disease Control and Prevention. “Maternal Mortality.” CDC, 2022.
9. American Society of Anesthesiologists. “Practice Guidelines for Obstetric Anesthesia.” ASA, 2021.
10. American Academy of Pediatrics. “Breastfeeding and Medication Use.” AAP, 2023.
11. American Academy of Pediatrics. "Magnesium Sulfate and Neuroprotection for Preterm Infants." AAP Clinical Report, 2018.
12. American College of Cardiology. "Hypertension in Pregnancy." ACC/AHA Guideline, 2017.